Brian Atwood

Brian Atwood

Director/Board Member at
Biotechnology Innovation Organization

Net worth: 246 $ as of 31/07/2026

73 year
Health Technology
Finance
Commercial Services

Profile

Brian G.
Atwood
founded Glycomed, Inc. in 1987, where he worked as President & Chief Executive Officer in 1995, Versant Ventures I LLC in 1999, where he worked as Managing Director, Versant Venture Management LLC in 1999, where he worked as Managing Director, and various other companies.
Mr. Atwood also founded PE Corp.
(New York), where he worked as Director and Perkin-Elmer Cetus Instruments, where he worked as Director.
Mr. Atwood also currently works at Biotechnology Innovation Organization, as Director, Launch One Acquisition Corp., as Independent Director from 2024, and CERo Therapeutics Holdings, Inc., as Director from 2024.
Mr. Atwood also formerly worked at Five Prime Therapeutics, Inc., as Chairman from 2002 to 2016, Veracyte, Inc., as Chairman from 2008 to 2016, Atreca, Inc., as Chairman from 2013 to 2024, and various other companies.
Mr. Atwood received his graduate degree from the University of California, Davis, undergraduate degree from the University of California, Irvine, and Masters Business Admin degree from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.03%
28/04/2026 24,591 ( 0.03% ) 246 $ 31/07/2026

Brian Atwood active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Brian Atwood

CompaniesPositionEnd
ATRECA, INC. Chairman 01/04/2024
Chairman 01/02/2024
CLOVIS ONCOLOGY, INC. Director/Board Member 10/07/2023
EFFECTOR THERAPEUTICS, INC. Chairman 01/08/2021
Founder 01/02/2018
See the detail of Brian Atwood's experience

Training of Brian Atwood

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

53

1st degree connections

38

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies38

Health Technology

Health Technology

Health Technology

Versant Ventures I LLC

Commercial Services

Commercial Services

Health Technology

Health Technology

Finance

Versant Ventures II LLC

Commercial Services

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

Finance

Consumer Services

Consumer Services

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Versant Ventures III LLC

Finance

Health Technology

Health Technology

Health Technology

Versant Ventures IV LLC

Health Technology

Health Services

Consumer Services

Perkin-Elmer Cetus Instruments

Health Technology

Finance

Finance

Cadence Pharmaceuticals , Inc.

Health Technology